title: [Preparation and release mechanism of gestodene reservoir-type intravaginal rings].
abstract: This study taking gestodene (GEST) as a model, investigated the factors affecting reservoir-type intravaginal ring (IVR)'s drug release. This paper reported a gestodene intravaginal ring of reservoir design, comprising a gestodene silicone elastomer core encased in a non-medicated silicone sheath, separately manufactured by reaction injection moulding at 80 degrees C and heating vulcanization at 130 degrees C is reported. The test investigated the factors affecting drug release through a single variable method, taking the drug release rates of 21 days as standards. When changing the thickness of the controlling sheath outside, the ratio of the first day of drug release and mean daily release (MDR), named the relatively burst effect, is closing to 1 with the thickness of controlling sheath increasing, while the 1.25 mm sheath corresponding to 1.04 controlled the burst release effectively; a positive correlation (r = 0.992 2) existed between the average drug release (Q/t) and drug loading (A) within a certain range. The C6-165 controlling sheath with high solubility of GEST is easier to achieve controlled release of the drug; GEST crystalline power is more effective to implement controlled release of drugs among difficent states of the drug. A 1/4 fractional segment core gives a relatively burst effect of 1.76, while the 1/1 and 1/2 are 1.93 and 1.87 separately, at the same drug loading, concluding that use of a fractional segment core would allow development of a suitable GEST reservoir IVR. In summary, GEST reservoir-type IVR could be adjusted by the thickness of controlling sheath, the loading of drug, the material properties of controlling sheath, the dispersion state of drug, the additive composition and structure of intravaginal ring, to control the drug release behavior and achieve the desired drug release rate.
authors: Chun-Xiao
authors: CX
authors: Li
authors: Yan-Kun
authors: YK
authors: Wang
authors: Mei-Ying
authors: MY
authors: Ning
mesh_terms: D000282:Administration, Intravaginal; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003274:Contraceptive Devices, Female; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems / Q000379:methods*; D009652:Norpregnenes / Q000008:administration & dosage* / Q000737:chemistry; D012826:Silicone Elastomers / Q000737:chemistry; D012995:Solubility
chemical_list: D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D009652:Norpregnenes; D012826:Silicone Elastomers; C033273:Gestodene